Shaimaa M Badr-Eldin,1,2 Osamaa AA Ahmed1,3 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy,
Badr-Eldin SM, Ahmed OAA
core
I The mode of action of a number of inhibitors of citrate synthase has been studied. The results suggest that ?-oxoglutarate acts as an allosteric inhibitor of the enzyme from Gram negative facultatively anaerobic bacteria, but as an isosteric inhibitor ...
Stephen. Harford (7701335)
core
Research progress on ATP-citrate lyase and its inhibitors: a metabolic-epigenetic perspective. [PDF]
Liu Q, Sun H, Dai L.
europepmc +1 more source
Correction: Radioprotective effects of ultra-small citrate-stabilized cerium oxide nanoparticles <i>in vitro</i> and <i>in vivo</i>. [PDF]
Popov AL +9 more
europepmc +1 more source
Functionalized magnetic nanoparticles orchestrate PI3K/AKT signaling to promote apoptosis in breast cancer cells. [PDF]
Durgadevi S, Kumar P.
europepmc +1 more source
Evaluating the Whole Blood Survival Advantage: How Citrate and Calcium Levels Drive Mortality in a Translational Swine Model of Polytrauma. [PDF]
Rall JM +8 more
europepmc +1 more source
Metabolite-Pool Networks and Biological-Non-Enzymatic Synergy in Volatile Flavor Formation by Lactic Acid Bacteria in Fermented Foods: A Review. [PDF]
Tong H, Li J, Jing Y, Tian B, Luo D.
europepmc +1 more source
Regional citrate anticoagulation combined with nafamostat mesylate for continuous kidney replacement therapy in septic acute kidney injury patients: protocol for a prospective, three-arm, randomised controlled study (RCNM-CKRT). [PDF]
Xu Q, Zou H, Zhou Z, Fu P, Zhang L.
europepmc +1 more source
SGLT2 Inhibitors in Nephrolithiasis: Emerging Evidence and What Urologists Need to Know. [PDF]
Ivănuță M +5 more
europepmc +1 more source

